D
Arbutus Biopharma Corporation ABUS
$3.51 $0.000.00%
Recommendation
Sell
Prev Close
$3.51
Volume
1,770,557
Avg Vol (90D)
885,280
Market Cap
$672.10M
Dividend & Yield
--
52-Week Range
$2.30 - $4.73
P/E (TTM)
--
EPS (TTM)
-$0.3807
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month
4/1/2025 - Simply Wall St
Harmony, Lungpacer, Verrica and Arbutus make C-suite hires
4/1/2025 - BizJournals.com - Nat'l Business News
All You Need to Know About Arbutus (ABUS) Rating Upgrade to Buy
3/31/2025 - Zacks Investment Research
Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?
3/31/2025 - Zacks Investment Research
Arbutus Biopharma (NASDAQ:ABUS) Rating Increased to Hold at StockNews.com
3/30/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Issues Quarterly Earnings Results
3/29/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Trading 4.1% Higher Following Strong Earnings
3/29/2025 - MarketBeat
Chardan Capital Reaffirms "Buy" Rating for Arbutus Biopharma (NASDAQ:ABUS)
3/29/2025 - MarketBeat
Arbutus Biopharma (ABUS, $3.5) price moved above its 50-day Moving Average on March 28, 2025
3/29/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $3.5) price may drop as it broke higher Bollinger Band on Mar 28, 2025
3/29/2025 - Tickeron - Stocks
Arbutus Biopharma (NASDAQ:ABUS) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS
3/28/2025 - Ticker Report
Arbutus Biopharma: A Wing And A Prayer
3/28/2025 - SeekingAlpha
What is Chardan Capital's Estimate for ABUS FY2025 Earnings?
3/28/2025 - MarketBeat
Arbutus Biopharma (ABUS, $3.27) price exceeded its 50-day Moving Average on March 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Arbutus Biopharma (ABUS, $3.27) entered Downtrend as Momentum indicator drops below 0 level on Mar 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates
3/27/2025 - Zacks Investment Research
Arbutus Biopharma Announces 2024 Financial Results and Strategic Restructuring
3/27/2025 - TipRanks Financial Blog
Arbutus Biopharma reduced workforce by 57%
3/27/2025 - The Fly
Arbutus Biopharma reports FY24 EPS (38c), consensus (55c)
3/27/2025 - The Fly
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
3/27/2025 - Globe Newswire
arbutus jettisons 57 staff ceases house research
3/27/2025 - FierceBiotech.com - Biotech
Arbutus Biopharma (ABUS, $3.39) price moved above its 50-day Moving Average on March 24, 2025
3/25/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $3.28) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 21, 2025
3/22/2025 - Tickeron - Stocks
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 6.3% - Here's What Happened
3/14/2025 - MarketBeat
Arbutus Biopharma (ABUS, $3.19) RSI Indicator left the oversold zone on March 12, 2025
3/13/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$6.17M
EBITDA (TTM)
-$72.31M
EBIT (TTM)
-$73.69M
Net Income (TTM)
-$69.92M
Balance Sheet
Total Assets (Q)
$131.71M
Total Debt (Q)
$6.12M
Total Liabilities (Q)
$34.34M
Book Value Per Share (Q)
$0.5126
Cash Flow
Cash from Operations (TTM)
-$64.85M
Cash from Investing (TTM)
$22.95M
Cash from Financing (TTM)
$52.00M
Net Change in Cash (TTM)
$10.05M
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.35
7-Day Total Return
4.15%
30-Day Total Return
2.03%
60-Day Total Return
7.34%
90-Day Total Return
2.03%
Year to Date Total Return
6.69%
1-Year Total Return
20.21%
2-Year Total Return
14.71%
3-Year Total Return
10.73%
5-Year Total Return
285.67%
52-week Low
Apr 03, 2024 - $2.30
52-week High
Sep 09, 2024 - $4.73
Valuation
Market Cap
$672.10M - Small Cap
Enterprise Value
$555.59M
Price/Sales (TTM)
108.00
Price/Book (Q)
6.85
Dividends and Shares
Shares Outstanding
189.70M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arbutusbio.com
Phone Number
267 469 0914
Address
701 Veterans Circle
Warminster, PA 18974
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of... more
NASDAQ 04/03/2025 4:00PM Eastern Quotes delayed
Weiss Ratings